Aktsiaselts Medical Pharmacy Group
Bankrupt Registry code 12356191
AS Tartu linn Registered 4 Oct 2012
Aktsiaselts Medical Pharmacy Group is a AS based in Tartu linn, registry code 12356191, status: bankrupt. Main activity: Manufacture of medicines and other pharmaceutical preparations. According to EMTA, turnover for Q3 2026 was €0 with employees.
Turnover
0 €
State taxes
—
Labour taxes
—
Employees
—
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Revenue · 2020 429 050 €above 65% of companiesindustry median 25 207 € · companies in the industry: 22
- Net profit margin · 2020 -150.5 %above 8% of companiesindustry median 7.1 % · companies in the industry: 14
Taxes and turnover
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | — | — | — | — |
| Q2 2026 | — | — | — | — |
| Q1 2026 | — | — | — | — |
| Q4 2025 | — | — | — | — |
| Q3 2025 | — | — | — | — |
| Q2 2025 | — | — | — | — |
| Q1 2025 | 24 590 | 5 410 | — | 1 |
| Q4 2024 | — | — | — | 1 |
| Q3 2024 | — | — | — | 1 |
| Q2 2024 | — | — | — | 1 |
| Q1 2024 | — | 9 050 | 4 577 | 7 |
| Q4 2023 | 34 922 | 7 256 | 6 714 | 8 |
| Q3 2023 | 40 116 | 24 598 | 17 479 | 8 |
| Q2 2023 | 40 548 | 806 | 607 | 7 |
| Q1 2023 | 46 373 | 17 327 | 10 248 | 8 |
| Q4 2022 | 66 174 | 34 190 | 27 382 | 9 |
| Q3 2022 | 40 183 | — | — | 8 |
| Q2 2022 | — | — | — | 7 |
| Q1 2022 | — | 10 715 | 7 724 | 8 |
Financials by year
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2020 | 429 050 | -645 803 | 366 170 | 706 275 | -1 341 457 | 15 |
| 2019 | 338 386 | -987 099 | 596 517 | 1 033 362 | -725 653 | 33 |
| 2018 | — | — | — | — | — | 34 |
| 2017 | — | — | — | — | — | 25 |
| 2016 | — | — | — | — | — | 21 |
| 2015 | — | — | — | — | — | 9 |
| 2014 | — | — | — | — | — | 0 |
| 2013 | — | — | — | — | — | 0 |
| 2012 | — | — | — | — | — | 0 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2020
Net profit margin
-150.5 %
Net profit / revenue
Return on assets (ROA)
-91.4 %
Net profit / assets
Equity ratio
-189.9 %
Equity / assets
Debt ratio
289.9 %
Liabilities / assets
Current ratio
0.13
Current assets / current liabilities
Revenue per employee
28 603 €
Revenue / average full-time employees
Labour cost per employee per month
2 034 €
Labour costs / employees / 12 months (incl. employer taxes)
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 18 Nov 2021 | Company’s own · audited | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 4 Oct 2021 | Company’s own · audited | e-Äriregister |
Board
- Nasdaq CSD SEKeeper of the share ledger · since 28 Sep 2017
- Kaidar SultsonBoard member · since 26 Mar 2025
- Jüri TruutsBankruptcy trustee · since 13 May 2024
Right of representation
Any member of the management board may represent the public limited company in all transactions.
Owners
No owner information.
Beneficial owners
- Swen UusjärvIndirect ownership · since 1 Oct 2018
Founders and other persons
- Worldlife Estonia OÜFounder · 2 500 € · 3 Oct 2012
- Aare OlanderAudit firm · 9 Apr 2019
- Gabler Audit OÜAudit firm · 12 May 2023
- Oleg TšernetsovChairman of the supervisory board · 14 Nov 2024
- Roland LuksSupervisory board member · 14 Nov 2024
- Ülari MetsaveerSupervisory board member · 14 Nov 2024
- Omanikukonto: Pre.IPO.Capital ASShareholder · 377 859 € · 6 Dec 2024
Related companies
Activities (EMTAK)
- 21201Manufacture of medicines and other pharmaceutical preparations Main
- 47911Retail sale via mail order houses or via Internet
- 9609Other personal service activities n.e.c.
History of changes
| What | Value | Period |
|---|---|---|
| Status | Bankrupt | 13 May 2024 – now |
| Status | Active | 4 Oct 2012 – now |
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 20061699 / 24 26 Mar 2025 |
Amendment entry | In force 26 Mar 2025 |
||
| Ä 20061699 / M14 13 Mar 2025 |
Ruling to eliminate deficiencies | 2 Apr 2025 | Deficiencies eliminated 19 Mar 2025 |
|
| Ä 20061699 / M13 4 Feb 2025 |
Procedural ruling | 11 Feb 2025 | In force 4 Feb 2025 |
|
| Ä 20061699 / 23 16 May 2024 |
Entry made by the register on its own initiative | In force 16 May 2024 |
||
| Ä 20061699 / 22 13 May 2024 |
Entry to enforce another court decision | In force 13 May 2024 |
||
| Ä 20061699 / M12 29 Feb 2024 |
Procedural ruling | 14 Mar 2024 | In force 29 Feb 2024 |
|
| Ä 20061699 / 21 26 Feb 2024 |
Amendment entry | In force 26 Feb 2024 |
||
| Ä 20061699 / M11 19 Nov 2021 |
Warning of compulsory dissolution: insufficient net assets | 18 May 2022 | In force 19 Nov 2021 |
|
| Ä 20061699 / 20 18 Nov 2021 |
Amendment entry | In force 18 Nov 2021 |
||
| Ä 20061699 / M9 4 Nov 2021 |
Public service of a ruling in Ametlikud Teadaanded | In force 4 Nov 2021 |
||
| Ä 20061699 / M10 4 Nov 2021 |
Public service of a ruling in Ametlikud Teadaanded | In force 4 Nov 2021 |
||
| Ä 20061699 / M8 29 Oct 2021 |
Demand to pay the state fee | 5 Dec 2021 | In force 7 Dec 2021 |
|
| Ä 20061699 / 19 29 Oct 2021 |
Entry made by the register on its own initiative | In force 29 Oct 2021 |
||
| Ä 20061699 / M7 21 Jul 2021 |
Fine for not filing the report | 6 Aug 2021 | In force 9 Aug 2021 |
|
| Ä 20061699 / 18 28 Jun 2021 |
Amendment entry | In force 28 Jun 2021 |
||
| Ä 20061699 / M6 14 May 2021 |
Warning of a fine: annual report not filed | 13 Jun 2021 | In force 14 May 2021 |
|
| Ä 20061699 / 17 20 Jan 2021 |
Amendment entry | In force 20 Jan 2021 |
||
| Ä 20061699 / 16 7 Dec 2020 |
Amendment entry | In force 7 Dec 2020 |
||
| Ä 20061699 / M5 24 Nov 2020 |
Ruling to eliminate deficiencies | 9 Dec 2020 | Deficiencies eliminated 7 Dec 2020 |
|
| Ä 20061699 / 15 12 Jul 2018 |
Amendment entry | In force 12 Jul 2018 |
||
| Ä 20061699 / 14 4 Jul 2018 |
Entry refused | In force 24 Jul 2018 |
||
| Ä 20061699 / 13 17 Jan 2018 |
Amendment entry | In force 17 Jan 2018 |
||
| Ä 20061699 / 12 23 Dec 2017 |
Amendment entry | In force 23 Dec 2017 |
||
| Ä 20061699 / 11 2 Dec 2017 |
Amendment entry | In force 2 Dec 2017 |
||
| Ä 20061699 / 10 28 Sep 2017 |
Amendment entry | In force 28 Sep 2017 |
||
| Ä 20061699 / M4 14 Mar 2017 |
Ruling to eliminate deficiencies | 3 Apr 2017 | Deficiencies eliminated 14 Mar 2017 |
|
| Ä 20061699 / 9 14 Mar 2017 |
Amendment entry | In force 14 Mar 2017 |
||
| Ä 20061699 / 8 14 Mar 2017 |
Amendment entry | In force 14 Mar 2017 |
||
| Ä 20061699 / 7 31 Jan 2017 |
Amendment entry | In force 31 Jan 2017 |
||
| Ä 20061699 / M3 26 Jan 2017 |
Ruling to eliminate deficiencies | 10 Feb 2017 | Deficiencies eliminated 31 Jan 2017 |
|
| Ä 20061699 / 6 19 Aug 2016 |
Transformation entry | In force 19 Aug 2016 |
||
| Ä 20061699 / M2 16 Aug 2016 |
Ruling to eliminate deficiencies | 15 Sep 2016 | Deficiencies eliminated 16 Aug 2016 |
|
| Ä 20061699 / 5 15 Jul 2016 |
Amendment entry | In force 15 Jul 2016 |
||
| Ä 20061699 / 4 1 Mar 2016 |
Amendment entry | In force 1 Mar 2016 |
||
| Ä 20061699 / 3 7 Jan 2016 |
Amendment entry | In force 7 Jan 2016 |
||
| Ä 20061699 / M1 30 Dec 2015 |
Ruling to eliminate deficiencies | 14 Jan 2016 | Deficiencies eliminated 7 Jan 2016 |
|
| Ä 20061699 / 2 19 Sep 2014 |
Amendment under Commercial Code § 525 (2) | In force 19 Sep 2014 |
||
| Ä 20061699 4 Oct 2012 |
First entry | In force 4 Oct 2012 |
Sources: e-Äriregister and EMTA. Data updated 2 Nov 2026. Open at the source ↗ · Report an error in the data